Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...

A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at ...

Researchers have identified chromosomal instability in circulating tumour cells as a prognostic and predictive biomarker in ...

New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...

Radiopharmaceutical therapy (RPT) combined with external beam radiotherapy (EBRT) is emerging as a powerful approach in prostate cancer treatment. Historically rooted in early 89Sr trials, this ...

Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy. When blocked, these enzymes cause the androgen receptor to collapse, ...

Scientists at EPFL and Johns Hopkins uncover the central role of an enzyme in controlling prostate cancer subtypes and ...

The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

Nigeria records over 18,000 new prostate cancer cases annually, accounting for the highest cancer burden among men in the country.

The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...